Filing Date | 
					T Date | 
					Ticker | 
										Sector | 
					Ind | Industry |  
						Owner | 
						oSt | 
						Rel | 
						Title | 
					 
					T | 
					TVal | 
					Price | 
					L | 
					Qty | 
					oc | 
					Own | 
					H | 
					r2y | 
					r1y | 
					r6m | 
					r3m | 
					r6w | 
					r3w | 
					r7d | 
					r3d | 
					f1d | 
					f1w | 
					f1m | 
					f3m | 
					f6m | 
					f1y | 
				
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/11/24 16:15  | 3/8/24  | DBVT | Health | BioPrd | Biological Products, (No Diag | Tasse Daniel | I0 | DO | CEO | P | 14 | 0.8300 | 0 | 17 | New | 17 | D | ||||||||||||||
2/8/24 17:02  | 2/6/24  | DBVT | Health | BioPrd | Biological Products, (No Diag | Ndu Adora | I0 | D | P | 2 | 0.8900 | 0 | 2 | New | 2 | D | |||||||||||||||
8/28/23 16:35  | 8/25/23  | DBVT | Health | BioPrd | Biological Products, (No Diag | Morris Timothy E | I0 | D | P | 18 | 1.52 | 0 | 12 | New | 12 | D | |||||||||||||||
8/3/23 16:40  | 8/1/23  | DBVT | Health | BioPrd | Biological Products, (No Diag | Soland Daniel B | I0 | D | P | 24 | 1.62 | 0 | 15 | 300 | 20 | D | 
| D | Derivative transaction in filing (usually option exercise) | 
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price | 
| A | Amended filing | 
| E | Error detected in filing | 
| S - Sale | Sale of securities on an exchange or to another person | 
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) | 
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company | 
| P - Purchase | Purchase of securities on an exchange or from another person |